Article
CPSA x Aimpoint 2026 Collaboration
CPSA Announces Exciting Collaboration with Aimpoint for 2026 Trial Programme
The CPSA is pleased to announce a new collaboration with Aimpoint, the world leader in red-dot sight technology, to launch a dedicated trial programme for the 2026-2027 season. This initiative will allow CPSA members to use the Aimpoint Acro S-2 & Micro S-1 sights across registered Sporting discipline shoots, including major championships, under controlled conditions designed to support shooters with eye dominance challenges.
Since its founding in 1975, Aimpoint has earned global recognition for precision, quality, and innovation in firearms technology. The Acro S-2, designed specifically for shotguns, offers a practical aid for shooters affected by eye dominance issues: helping them to regain balance, confidence, and enjoyment in the sport. Around 30–40% of shooters experience some form of eye dominance, which can affect their performance and enjoyment of the sport. The CPSA recognises its duty to support these members, and the Aimpoint Acro S-2 trial provides a practical way to help them participate with confidence.
Through this trial, the CPSA aims to support inclusion and accessibility in clay shooting while safeguarding the integrity of our competitions. CPSA members who register to take part will be able to shoot targets only with an Acro S-2 at registered ESP events, including championships. Aimpoint has committed to a generous prize fund to be used across Sporting championships for these shooters, as well as to producing educational content and hosting Have-a-Go sessions at key CPSA events. In addition, there will be Aimpoint-sponsored places at our Sporting championships for registered shooters, providing opportunities for a dedicated squad of Acro S-2 users to compete together.
Iain Parker, Chief Executive of the CPSA, commented on the collaboration:
‘We’re excited to work with Aimpoint on this new initiative. Our goal is to help members affected by eye dominance conditions continue to enjoy and progress in the sport. This collaboration allows us to explore new solutions responsibly, ensuring fairness while offering genuine support to those who may benefit.’
The CPSA will monitor the trial across an 18 month – 2 year period, reviewing performance data and member feedback before making any decisions on long-term use of the Aimpoint Acro S-2 in CPSA-registered competitions.